chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A couple of hours after the injection 02/05/2021, I had pain and heaviness at the site of the injection. The pain made me feel as though it had doubled the size, but physically it was the same size. The next day, 02/06/2021, I woke up to a tremendous itching and I looked and it was a major swelling at the site, and a huge area of a rash. It was extraordinarily itchy and I couldn't scratch it. I sent the Dermatologist a pic of the arm and he had me come in at 8:00 AM on 02/08/2021. Dr. diagnosed as a reaction to the shot and it will clear in time. The doctor was concerned about the reaction I would have with the second shot. He prescribed an ointment that was very strong, I used it twice a day, morning and night, It took 9 days for the rash to subside. 03/05/2021, I had the 2nd Dose of Moderna, LOt# 029A21A nothing happened on Friday, I woke up on Saturday. my brain felt like it was in a cocoon. I was physically tired,  I felt like my brain was toast as though I had anesthesia. The next day Sunday I was fine.
MODERNA COVID VACCINE #3 GIVEN 10/11/21, LOT #002C21A; 6/15/22 pt found to be positive for COVID in SNF; pt had been on hospice in facility; 6/23/22 pt admitted to hospital after a fall; laceration to left hand; encephalopathic; hospice revoked due to hospitalization; found to be positive for COVID; pt's condition worsened; admitted for GIP hospice; pt passed away in the hospital
fever, nausea,  flu like symptoms Saturday and Sunday.  Just took Tylenol and ibuprofen.
DEVELOPED HIGH-PITCHED SCREAMING WHEN LAYED DOWN, ARCHING OF BACK TREMOR AND OPEN, GLAZED EYES WITHIN AN HOUR OF FIRST IMMUNIZATIONS. THESE SYMPTOMS LASTED ABOUT A WEEK BUT TOOK ABOUT 3 WEEKS TO GET BACK TO NORMAL.
Vaccine was given 7 days past beyond use date. Per Pfizer, their data stated, "Stability assessment indicates there is no product quality impact and the vaccine was suitable for use."
Varicella vaccine on 12/17/96. Varicella disease on 6/2/01 onset.
Initially soreness at injection site, headache, flu-like symptoms. Lasted 3 days, followed by swelling in face and hands, yellow fluid leaking from skin on face, and rash on face and left arm. Right eye swollen almost shut. Went to ER on 4/29/2019 at 7:30 a.m.  CT revealed preceptal cellulitis of right eye. Admitted to hospital same day. Rash spread all over face, chest, arms, hands, torso, and right leg. Was given IV Vancomycin, Cefapime, Rocephin, Acyclovir. Swelling of face resolved after 5 days. Released from hospital and given oral amoxicillin 500 mg t.i.d. for 7 days. Rash on face and chest crusted up and resolved to a tolerable level two weeks later, with residual itching, irritation, tingling and
Nausea, severe headache, soreness at injection site, swelling behind right knee and above left knee.
Symptoms include erythema, swelling with itching, and warmth on left upper and lower extremity. Treated with BENADRYL every 4 hours as needed.
Initial report received on 11 June 2009 from a consumer.  A 23 year old female patient with a history of hydrocodiene, peanuts, iodine, red eye allergies received ADACEL (lot number not known) in the right deltoid intramuscularly on an unknown date.  An hour and a half post vaccination, the patient reported that she had an increased heart rate, itching in her throat, and dizziness.  The patient's recovery status was unknown.  List of Documents held by Sender: none.
left shoulder was aching all night; left shoulder was throbbing all night; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (left shoulder was aching all night) and VACCINATION SITE PAIN (left shoulder was throbbing all night) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021 at 8:30 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced ARTHRALGIA (left shoulder was aching all night) and VACCINATION SITE PAIN (left shoulder was throbbing all night). At the time of the report, ARTHRALGIA (left shoulder was aching all night) and VACCINATION SITE PAIN (left shoulder was throbbing all night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Pain and soreness in the location of injection immediate. After 2 hours, I begun to feel tired and got soreness, muscle pain and joint pain and stiffness, nausea, fever, shortness of breath, severe headaches, stomach pain, shivering. The fever was severe within 10 hours for 10 hours and susided but continued on for 24 hours. Most symptons are gone by 7 AM on 3/14/2018. Mild muscles pain and joint aches continued.
CDC reports: 2 yo child developed fever to 105 & irritability following DTP/OPV/MMR immunization.
Over night:  reddness, pain, swelling (appears to be almost cellulitis)from below injection site to elbow on the inside of the left arm. 10/23/09 made DR's appt and was prescribed cortisone cream to be applied.
Information has been received from a 69 year old female patient with hypertension, arthritis, drug hypersensitivity to "NASOTEC", Prednisone, Piperacillin/ Tazobactam and a history of gastric bypass who in December 2007, was vaccinated with ZOSTAVAX (Merck). Concomitant therapy included Alprazolam, Estrogens, vitamins and minerals. In January 2009, the patient experienced a herpes lesion (cold sore) on her lip which had then expanded to the inside of her mouth. The patient said if felt like a "blister that won't open and is inflamed". The patient had been using hot compresses and had a biopsy by her plastic surgeon. She went to the ER as a result of complication of the biopsy. The patient had sought medical attention and was not recovered at the time of reporting. Follow up information has been received from a medical assistant concerning the 69 year old retired female patient with drug hypersensitivity to mylogram dye, enalapril maleate (MSD), Prednisone and Piperacillin / Tazobactam (ZOSYN) who on 07-Dec-2007 at 14:36 was vaccinated with ZOSTAVAX (Merck) subcutaneous injection into the left upper arm(lot# 68396/ 0967U). On 10-Dec-2007, the patient experienced redness and pain-increased pain with movement and cellulitis. She had sought medical attention and subsequently recovered. Follow up information has been received from a nurse that the 69 year old female patient had cellulitis at the site where the lesion was biopsied. The patient had pain with movement of her mouth at the time. The patient subsequently experienced allergy while on therapy with Enalapril maleate (MSD, WAES#0905USA02813) Additional information has been requested.
Pt c/o redness, swelling and itchy @ site 3cm x 2cm raised rash R upper arm with Sl blistering . Benadryl + Ibuprofen PRN, cold compresses to area advised by MD.
Hospitalization for SOB, COVID19 8/14/21-8/17/21
covid vaccine breakthrough case   dose 1  Moderna  3/26/2021 018B21A dose 2  Moderna  4/23/2021  040B21A
Redness, swelling, itching at site of injection. Seen at hospital and prescribed Cephalexin for infection 8/28/03.
Initial and follow up information has been received from a physician, via the Merck pregnancy registry, concerning a 16 year old female patient with gonorrhea ("around the time of her first dose"), a date of LMP on 26-DEC-2006 and no prior pregnancies, who on 23-JAN-2007 was vaccinated IM, with the first dose, 0.5ml, of Gardasil (Lot #654510/0962F).  On the day of vaccination (23-JAN-2007), a pregnancy test was negative.  However, on 13-FEB-2007, at a follow up appointment, a pregnancy test was positive.  Follow up information indicated that in May 2007, an ultrasound result showed a normal fetus.  Prenatal vitamins and an iron supplement were prescribed for daily use during pregnancy.  There were no complications during pregnancy.  On 03-OCT-2007, a normal, 6 pound 11 ounce, 19 inch long, female infant was born, at gestation week 40.  The infant's Apgar score was 8.1/9.5.  There were no complications during delivery.  No other details were provided.  Follow up information from the physician, indicated that the infant was born with a congenital nevus, described as "dark brown nevus lt. frontal bone," and had also had eczema "since birth."  On 22-OCT-2007, at age 19 days, the infant was seen in the physician's office, for "crying too much," and irritability.  There was no fever, no respiratory distress, no cough, but the infant did have sneezing.  The physician recommended that feeding be decreased to 1-2 oz every 2 hours.  Skin was noted as normal.  On 05-NOV-2007, the infant was seen in follow up, and the mother reported concerns about the infant's dry skin.  The infant was reported to be "doing well."  On 13-DEC-2007, the infant was seen in the office, with noted seborrheic dermatitis on the scalp and behind the ears, and dry skin and eczema.  Treatment included hydrocortisone 2.5% for eczema, and SELSUN shampoo for seborrheic dermatitis.  Vaccinations at this visit included a dose of the following: PEDIARIX, PREVNAR, Hib conj vaccine (OMPC) (MSD) and Rotateq (MSD).  The patient was to return in 2 months.  On 04-JAN-2008, the infant visited the clinic and was given hydrocortisone 2.5 % and SEBULEX shampoo.  On 29-FEB-2008, the physician noted at a visit, that the infant had "bad eczema since birth," that "flared up around 8 wks of age and never resolved."  The infant had been scratching and itching her skin, with some resultant bleeding.  The infant also had a runny nose with clear drainage "for the past couple days as well as a dry cough."  One loose stool was noted the day prior to the visit and on the day of visit.  The physician noted erythematous areas on the arms, legs, back of neck.  Treatment with hydrocortisone continued and desonide cream was prescribed.  An upper respiratory infection was also diagnosed.  The infant was vaccinated with another dose of Hib conj vaccine (OMPC) (MSD), PEDIARIX and PREVNAR.  No further details were provided.  Additional information is not expected.  Medical records provided on request.
Diagnosed with chronic kidney disease, they referred me to a nephrologist, have just been tested. I have not had treatment. I had UTI, was tested for COVID that was negative, treated in antibiotics, September 2021. Those symptoms have since resolved.
6 days after vaccine, began to develop a rash on left side of neck that physician diagnosed as shingles on 4-1-21.
Swollen and sore lymph nodes (under both arm pits).  Soreness started to lessen within a few days, however while less sore, there is still noticeable mild soreness 4 weeks later
This spontaneous report as received from a healthcare worker refers to 2 patients of unknown demographics. The pertinent medical history was not reported. On 12-FEB-2015 the patients were vaccinated with an expired dose of ZOSTAVAX (lot # J000853, Expiry date: 23-APR-2014). No adverse effects were reported. The outcome of the event was unknown. Additional information has been requested.
Chest pain, started 04/29/2021, managed with rest and OTC pain reliever, ended 05/02/2021. Panic attacks, started 04/30/2021, managed with Valium, ended 05/04/2021 Suicidal ideation, experienced with both doses. Dose 1, started 04/01/2021, ended 04/11/2021. Dose 2, started 04/30/2021, ended 05/04/2021
This spontaneous report was received on 12-JUL-2017 from a pediatric physician and refers to an unspecified patient of unknown age and gender. The physician reported that the patient received an improperly stored dose of VARIVAX (Lot number M042496, expiration date 19-OCT-2018) (Dose, route, site of administration not reported) and properly stored sterile diluent (M029027, expiration date 14-MAR-2019) for prophylaxis on 11-JUL-2017. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. The VARIVAX (Lot number M042496, expiration date 19-OCT-2018) had the following temperature excursion reported: The temperature was reported as 6 degrees Fahrenheit (F) to 14 degrees Fahrenheit (F) for the time frame of 1 hour. It was administered. There was no previous temperature excursion. The call was because of a "data logger". Product quality complaint was not involved. No adverse effects reported. No additional information was provided. Additional information has been requested.
Patient went to doctor's office and complained of pain in shoulder that radiated to the arm.  Doctor said a possible explanation could be due to flu vaccine.
This spontaneous report was received from a Medical Assistant, referring to a patient of unknown age and gender. Information about the patient's medical history and concurrent conditions was not provided. On 27-MAY-2016, the patient was vaccinated with an improperly stored dose of VARIVAX lot# L034370; expiration date: 08-AUG-2017 (administration route was not provided). No concomitant therapies were reported. No adverse effects were reported. The vaccine underwent a temperature excursion (10F) for a time frame of 3 hours and 16 minutes. No previous temperature excursions were reported. This is one of several reports from the same reporter. Additional information has been requested.
Severe nausea, with vomiting, which started approximately 9 hours after the injection. This also included body aches, chills, mild fever, and dizziness. Vomiting lasted for approximately 2 hours, but nausea persisted for approximately 2 days. A significant migraine occurred approximately 6 hours after the injection, and lasted approximately 6 hours.
Shot given at 10:10am. Came to office complained of itchy to arms and hands at 11:45. Left arm 4" diameter red area. Benadryl 25mg by mouth at 12 noon and 12 pm. Complaining of neck feeling itchy. Ice pack to Left arm upon arrival. Driven to hospital. Denied shortness of breath. Hospital arrival-felt better. Receives steroid alot and prescription Prednisone, Pepcid. Returned to work 12-7-06.
"Pt c/o of facial and tongue numbness 5 minutes after receiving his vaccine. Denies any hx of allergies or taking any medication. Negative for hives or tongue/throat swelling. Denies difficulty swallowing or breathing.    Water, juice, and Graham crackers given. Vital sign stable BP 115/87, HR 71, RR16, SPO2 100%.    Symptoms resolved 45 min later. ER precaution advised. Pt d/ced in stable condition. "
received dose 14 days past expiration date; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received HAV (Havrix) (batch number unknown, expiry date 13th October 2022) for prophylaxis.   On an unknown date, the patient received Havrix. On an unknown date, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 24-Oct-2022 Reporter's comment: The clinic manager reported that the patient received a dose of Havrix 14 days past the expiration date.  The clinic manager reported the expiration date for the dose given was 13 Oct 2022.  The reporter consent to follow up. The reporter did not consent to account creation.  The reporter contact information for follow up would be sent mailbox. Additional supportive information: The patient was administered an expired dose of Havrix, which led to expired vaccine used.
testedpositive for Covid-19 2 weeks after she got her 2nd; testedpositive for Covid-19 2 weeks after she got her 2nd; soreness on the area; This is a spontaneous report from a contactable consumer and received via from a Pfizer-sponsored program. A 71-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number was not reported) via an unspecified route of administration on 17Feb2021 as single dose and first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Lot number was not reported) via an unspecified route of administration on 27Jan2021 for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient underwent lab tests and procedures which included sars-cov-2 test result was positive on an unspecified date. The patient tested positive for Covid-19 2 weeks after she got her 2nd dose last 17Feb2021 she took 5 aleve for the soreness on the area. Transfer to the fact sheet. Submitted a manual AE form. The outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
Muscle pain; couldn't run or walk without terrible pain; left arm is still sore; Headache; pain everywhere in her body; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 16Feb2021 12:10 (Lot number: EN6200) at the age of 68 years as dose 2, single for COVID-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162B2 (dose 1, lot no. EL9261), administration date: 26Jan2021, when the patient was 68 years old, for COVID-19 immunisation. The following information was reported: MYALGIA (non-serious) with onset 16Feb2021, outcome "not recovered", described as "Muscle pain"; GAIT DISTURBANCE (non-serious) with onset 16Feb2021, outcome "not recovered", described as "could not run or walk without terrible pain"; PAIN IN EXTREMITY (non-serious) with onset 16Feb2021, outcome "not recovered", described as "left arm is still sore"; HEADACHE (non-serious) with onset 16Feb2021, outcome "not recovered", described as "Headache"; PAIN (non-serious) with onset 16Feb2021, outcome "not recovered", described as "pain everywhere in her body". Therapeutic measures were not taken as a result of myalgia, gait disturbance, pain in extremity, headache, pain.  Additional information: Clinical course: Patient said her side effects began 4-5 hours later. She said that the questionnaire she answered asked about side effects for the first hour or so, but that did not happen. She said that her side effect was that she was curled up on the floor in a little ball in pain, that was not muscle aches like what is listed as a potential side effect, this was muscle pain, really bad pain. She said that this persisted, and she was a runner and a couple weeks later she could not run or walk without terrible pain. She said her left arm was still sore, and she has done no treatment. She said she wonders if she was going to have to put up with this pain for the rest of her life. She said that she has the pain when she was active, a month later, and she would like to know what would cause pain like this. She said who knew, but she can tell that was related to the vaccine as it started 4-5 hours later that she was in pain everywhere in her body; headache and body. She said that the next day she was obviously functioning, and she was a runner so a week or two later when she goes to run or walk she had terrible pain that showed up again and again. She said she was assuming eventually it will go away.   No follow-up attempts are possible. No further information is expected.
Unknown pain in the whole body, progressive to the point of unable to do exercise and move.  As time progressed pain in the whole body had reduced - staying only in hands and feet.
This spontaneous report as received from a registered nurse refers to a 17 years old female patient with no pertinent medical history and no drug reactions or allergies. The patient was inadvertently vaccinated with a 0.65 ml dose of ZOSTAVAX (Lot # H013021, expiration date 09-OCT-2013) SQ on 10-DEC-2012 instead of VARIVAX (Merck). No other co-suspects were reported. No concomitant medications were reported. The nurse reported that on 11-DEC-2012, the patient reported that the injection site was red and swollen, although size of swelling was unspecified. The patient did not receive treatment for the adverse events. There were no Lab diagnosis or studies performed. The patient stated that the injection site was improving. Additional information has been requested.
Shortly after the vaccine, I did not feel well, sick at the stomach, nausea, slight temperature, for 3 days. I did not have these symptoms with the other doses. Scalp was getting irritated in October, it was itching all the time; On Nov I got an appointment with the doctor, she prescribed medication for me, I started taking medication, I went for another allergy shot, both arms were swealing for two weeks, after the COVID-19 shot. For 2 weeks were red and swallow, I put ice, I called dermatologist & allergist and told me to keep putting ice and see what happened.
Mom informed me (on 8/24/2023) that he had swollen, red cheeks as well as a sore throat about 24 hours after his vaccines. She gave him benadryl and felt that helped his symptoms. Took him to the ED on 6/2- in the evening. symptoms resolved 48 hours after receiving vaccine.
Large red, hot,swollen, itchy rash which lasted approx 10 days.
Chills; Fever; Extreme fatigue; Headache; This is a spontaneous report from a non-contactable consumer. A 49-year-old male patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: ER8736), dose 2 via an unspecified route of administration, administered in Arm Left on 10Jun2021 17:30 (Batch/Lot Number: ER8736) as dose 2, single for covid-19 immunisation (at the age of 49-year-old). Medical history included covid-19 and arthritis from an unknown date and unknown if ongoing. Not known allergies. There were no concomitant medications. The patient previously received first dose of bnt162b2 on 20May2021 05:30 PM in arm left as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not received any other medications within 2 weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 11Jun2021 01:00 AM patient experienced chills and fever with extreme fatigue and headache. The outcome of the event was recovering.  No follow-up attempts are possible. No further information is expected.
Patient had received the Mederna Vaccine the first 2 doses of COVID 19 vaccine. Patient came in and received the Pfizer vaccine for COVID 19 . as the 3rd dose. Patient did not have any signs or symptoms of adverse reaction to having received the 3rd dose as the Pfizer rather than the Mederna.
Patient arrived back to the vaccine room at 1745 indicating she started experiencing fatigue and lightheadedness about 10 minutes after receiving the vaccine.  She attempted to return to work but felt "slow."  B/P 130/94, HR 70, Oxygen saturation 98%, Temp. 99.4.  Patient laid down and drank juice.  She felt some better before calling a family member to come pick her up.
Vaccination site hard, warm, tender, red, blotchy, and itchy. Denies SOB or difficulty breathing. Utilizing Benadryl and cold compress.
About 24 hours after 2nd Moderna vax, got a moderate to severe headache in addition to mild to moderate body aches and a low grade fever. Side effects resolved significantly the morning after (2/18).
swollen arm from elbow down to fingers; hand turning blue; advise contact MD immed; MD determined it was reaction to Td per info from parent 25MAR93;
Patient was admitted to Medical Center with transverse myelitis, potentially caused by second Moderna vaccine received on 3/16/21